158 related articles for article (PubMed ID: 9452271)
21. Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Juniewicz PE; Barbolt TA; Egy MA; Frenette G; Dube JY; Tremblay RR
Prostate; 1990; 17(2):101-11. PubMed ID: 2169047
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
23. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
[TBL] [Abstract][Full Text] [Related]
24. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
Furr BJ
Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Cho YM; Takahashi S; Asamoto M; Suzuki S; Tang M; Shirai T
Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
[TBL] [Abstract][Full Text] [Related]
26. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
[TBL] [Abstract][Full Text] [Related]
27. CSL regulates AKT to mediate androgen independence in prostate cancer progression.
Wang H; Zhang L; Fu Y; Fang F; Jiang Y; Dong Y; Zhu W
Prostate; 2016 Feb; 76(2):140-50. PubMed ID: 26437743
[TBL] [Abstract][Full Text] [Related]
28. Effects of finasteride and bicalutamide on prostatic blood flow in the rat.
Lekås E; Bergh A; Damber JE
BJU Int; 2000 May; 85(7):962-5. PubMed ID: 10792183
[TBL] [Abstract][Full Text] [Related]
29. Direct effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in castrated F344 rats.
Mori T; Cui L; Kato K; Takahashi S; Imaida K; Iwasaki S; Ito N; Shirai T
Jpn J Cancer Res; 1996 Jun; 87(6):570-4. PubMed ID: 8766519
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitors.
Bühler P; Fischer T; Wolf P; Gierschner D; Schultze-Seemann W; Wetterauer U; Elsässer-Beile U
Urol Int; 2010; 84(2):203-11. PubMed ID: 20215827
[TBL] [Abstract][Full Text] [Related]
31. [Promotional effects of high fat diet on chemical carcinogenesis of the prostate].
Takai K
Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):871-80. PubMed ID: 1715414
[TBL] [Abstract][Full Text] [Related]
32. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
Miller NL; Bissonette EA; Bahnson R; Wilson J; Theodorescu D
Cancer; 2003 Mar; 97(5):1203-10. PubMed ID: 12599226
[TBL] [Abstract][Full Text] [Related]
33. Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2'-dimethyl-4-aminobiphenyl.
Shirai T; Nakamura A; Fukushima S; Yamamoto A; Tada M; Ito N
Carcinogenesis; 1990 May; 11(5):793-7. PubMed ID: 2335007
[TBL] [Abstract][Full Text] [Related]
34. Slight promotion effects of intermittent administration of testosterone propionate and/or diethylstilbestrol on 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Cui L; Mori T; Takahashi S; Imaida K; Akagi K; Yada H; Yaono M; Shirai T
Cancer Lett; 1998 Jan; 122(1-2):195-9. PubMed ID: 9464510
[TBL] [Abstract][Full Text] [Related]
35. Casodex: preclinical studies.
Furr BJ
Eur Urol; 1990; 18 Suppl 3():2-9. PubMed ID: 2094608
[TBL] [Abstract][Full Text] [Related]
36. Sequential observation of rat prostate lesion development induced by 3,2'-dimethyl-4-aminobiphenyl and testosterone.
Shirai T; Imaida K; Iwasaki S; Mori T; Tada M; Ito N
Jpn J Cancer Res; 1993 Jan; 84(1):20-5. PubMed ID: 8449822
[TBL] [Abstract][Full Text] [Related]
37. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
[TBL] [Abstract][Full Text] [Related]
38. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.
Umekita Y; Hiipakka RA; Kokontis JM; Liao S
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11802-7. PubMed ID: 8876218
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural and quantitative immunohistochemical changes induced by nonsteroid antiandrogens on pituitary gonadotroph population of prepubertal male rats.
Cónsole GM; Jurado SB; Rulli SB; Calandra RS; Gómez Dumm CL
Cells Tissues Organs; 2001; 169(1):64-72. PubMed ID: 11340263
[TBL] [Abstract][Full Text] [Related]
40. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
